Role of laparoscopy in the diagnosis and treatment of prostate cancer

Seminars in Surgical Oncology

Volumn 12, Issue 2, 1996, Pages 139-144

  Moore, Robert G ^a,b   Partin, Alan W ^a   Kavoussi, Louis R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

gene therapy; laparoscopy; prostate cancer

Indexed keywords

GENE THERAPY; HUMAN; LAPAROSCOPY; LYMPH NODE DISSECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SURGICAL TECHNIQUE;

COMBINED MODALITY THERAPY; GENE THERAPY; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 0029996138     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199603/04)12:2<139::AID-SSU9>3.0.CO;2-A     Document Type: Review

References (51)

1. Walsh PC: The natural history of localized prostate cancer: a guide to therapy. In Walsh PC Retik AB, Stamey TA, Vaughan ED (eds): "Campbell's Urology Update, No. 13." 1995, 1-8.
2. Blasko JC, Ragde H, Grimm PD, et al: Transperitoneal ultrasound guided palladium - 103 Brachy therapy for prostate cancer (abstr). J Urol 153:385A, 1995.
3. Shinohara K, Carroll, PR: Improved results of cryosurgical ablation of the prostate (abstr). J Urol 153:385A, 1995.
4. Gelet A, Chapelon JY, Bouvier R, et al: Treatment of organ confined prostatic cancer by high intensity focused ultrasound (HIFU) delivered by transrectal route: pilot Study (abstr). J Urol 153:386A, 1995.
5. Griffith DP, Schuessler WW, Nickell KG, Meaney JT: Laparoscopic pelvic lymphadenectomy for prostatic adenocarcinoma. Urol Clin N Am 19:407-415, 1992.
6. Schuessler WW, Vancaillie TG, Reich H, Griffith DP: Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol 145:989-991, 1991.
7. Mukamel E, Hannah J, Barbaric Z, Dekernion JB: The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological stage. J Urol 136:1231-1233, 1986.
8. Rifkin MD, Zerhouni EA, Gatsonis CA, et al: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional trial. N Engl J Med 323:621-626, 1990.
9. Schubert J, Heidl G: The value of various methods for determining lymphatic metastases in prostatic carcinoma. Eur Urol 9:257-261, 1983.
10. VanPoppel H, Ameye F, Oyen R, et al: Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostate cancer. J Urol 151:1310-1314, 1994.
11. Flanigan RC, Mohler JL, King CT, et al: Preoperative lymph node evaluation in prostate cancer patients who are surgical candidates: the role of lymphangiography and computerized tomography scanning with directed fine needle aspiration. J Urol 134:84, 1985.
12. Petros JA, Catalona WJ: Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147:1574-1575, 1992.
13. Kavoussi LR: Editorial: techniques for nodal staging in prostate cancer. J Urol 151:1324-1325, 1994.
14. Danella JF, DeKernion JB, Smith RB, Steckel J: The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149:1488-1491, 1993.
15. Bluestein DL, Rostwich DG, Bergstrallt EJ, Osterlmg JE: Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151:1315-1320, 1994.
16. Bishoff JT, Reyes A, Thompson IM, et al: Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45:270-274, 1995.
17. Partin AW, Yoo J, Carter HB, et al: The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-114, 1993.
18. Partin AW: Letter to editor. J Urol 152:172-173, 1994.
19. Moore RG, Kavoussi LR: Laparoscopic lymphadenectomy in genitourinary malignancies. Surg Oncol 2(Suppl 1):51-66, 1993.
20. Kerbl K, Clayman RV, Petros JA, et al: Staging pelvic lymphadenectomy for prostate cancer: a comparison of laparoscopic and open techniques. J Urol 150:396-399, 1993.
21. Parra RO, Andrus C, Boullier J: Staging pelvic lymph node dissection: comparison of results with open pelvic lymphadenectomy. J Urol 147:875-878, 1992.
22. Winfield HN, See WA, Donovan JF, et al: Comparative effectiveness and safety of laparoscopic vs. open pelvic lymph node dissection for cancer of the prostate (abstr). J Urol 147:244A, 1992.
23. McDowell GC, Johnson JW, Tenney DM, Johnson DE: Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urology 35:476-482, 1990.
24. Das S, Tashima M: Extraperitoneal laparoscopic staging pelvic lymph node dissection. J Urol 151:1321-1323, 1994.
25. Gauzzoni G, Montorsi F, Bergamaschi F, et al: Open surgical revision of laparoscopic pelvic lymphadenectomy for staging of prostate cancer: the impact of laparoscopic learning curve. J Urol 151:930-933, 1994.
26. Troxel SA, Winfield HN: Comparative financial analysis of laparoscopic pelvic lymph node dissection (LPLND) performed in 1990-91 versus 1993-94 (abstr). J Urol 153:357A, 1995.
27. Kavoussi LR, Sosa G, Chandhoke P, et al: Complications of laparoscopic pelvic lymph node dissection. J Urol 149:322-325, 1993.
28. Ruckle HC, Lang GS, Hutton D, et al: Complications of first 100 laparoscopic pelvic lymph node dissections: comparative analysis of first 50 vs. second 50 cases (abstr). J Urol 149:417A, 1993.
29. McCullough DL, McLaughlin AP, Gittes RF: Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostate cancer. J Urol 117:206-207, 1977.
30. Paul DB, Loening SA, Narayana AS, Culp DA: Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 129:1141-1144, 1983.
31. Brendler CB, Cleeve LK, Anderson EE, Paulson DF: Staging pelvic lyrnphadenectomy for carcinoma of the prostate - risk versus benefit. J Urol 124:849-50, 1980.
32. Moore RG, Kavoussi LR, Bloom DA, et al: Post-operative adhesion formation after urologic laparoscopy in the pediatric population. J Urol 153:792-795, 1995.
33. Moore RG, Partin AW, Adams JB, Kavoussi LR: Adhesion formation following transperitoneal nephrectomy: laparoscopic vs. open approach. J Endourol 9:277-280, 1995.
34. Glascock, JM, Winfield HN, Donovan JB, et al: Staging adenocarcinoma of the prostate: a survey of the first 200 laparoscopic pelvic lymphadenectomies (LPLND) (abstr). J Urol 153:382A, 1995.
35. Troxel J, Winfield HN: Comparative financial analysis of laparoscopic versus open pelvic lymph node dissection for men with cancer of the prostate. J Urol 151:675-680, 1994.
36. Schuessler WW: Laparoscopic radical prostatectomy. J Urol (in press).
37. Levy DA, Resnick MI: Laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy: a viable alternative to radical retropubic prostatectomy. J Urol 151:905-908, 1994.
38. McDowell GC II, Babaian RJ, Johnson DE: Management of symptomatic lymphocele via percutaneous drainage and sclerotherapy with tetracycline. Urology 37:237-239, 1991.
39. Weldon VE, Travel FR: Potency-sparing radical perineal prostatectomy: anatomy, surgical technique and initial results. J Urol 140:559-562, 1988.
40. Resnick MI: Radical prostatectomy redux. Contemp Urol 3:44-53, 1991.
41. Kavoussi LR, Schuessler WW, Vancaillie TG, Clayman RV: Laparoscopic approach to seminal vesicles. J Urol 150:417-419, 1993.
42. Teichman JMH, Reddy PK, Hulbert JC: Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer. Urology 45: 823-830, 1995.
43. Waples MJ, Wegenke JD, Vega RJ: Laparoscopic management of lymphadenectomy and radical retropubic prostatectomy. Urology 39:82-84, 1992.
44. Bardot SF, Montie JE, Jackson CL, Seiler JC: Laparoscopic surgical technique for internal drainage of pelvic lymphocele. J Urol 147:908-909, 1992.
45. Parra RD, Jones JJ, Hagood PG: Laparoscopic marsupialization of lymphoceles (abstr) J Urol 147:449A, 1992.
46. Gill JS, Hodge EE, Munch LC, et al: Transperitoneal marsupialization of lymphoceles: a comparison of laparoscopic and open techniques. J Urol 153:706-711, 1995.
47. Boring CC, Squires TS, Tone T: Cancer statistics. 43:7-26. 1993.
48. Hsieh WS, Simons JW: Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biology. Cancer Treat Rev 19:229-260, 1993.
49. Partin AW, Piantadosi S, Sanda MG, et al: Selection of men at high risk for experimental adjuvant therapy following radical prostatectomy. Urology 45:831-838, 1995.
50. Sanda MD, Ayyagari RS, Jaffee EM, et al: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151:622-628, 1994.
51. Pearle MS, Nakada SY, McDougall EM, et al: Laparoscopic pneumodissection: initial clinical experience. Urology 45:882-885, 1995.